Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey.
Lievens Y, Defourny N, Coffey M, Borras JM, Dunscombe P, Slotman B, Malicki J, Bogusz M, Gasparotto C, Grau C; HERO Consortium; Kokobobo A, Sedlmayer F, Slobina E, Coucke P, Gabrovski R, Vosmik M, Eriksen JG, Jaal J, Dejean C, Polgar C, Johannsson J, Cunningham M, Atkocius V, Back C, Pirotta M, Karadjinovic V, Levernes S, Maciejewski B, Trigo ML, Šegedin B, Palacios A, Pastoors B, Beardmore C, Erridge S, Smyth G, Cleries Soler R. Lievens Y, et al. Among authors: erridge s. Radiother Oncol. 2014 Aug;112(2):178-86. doi: 10.1016/j.radonc.2014.08.034. Epub 2014 Nov 12. Radiother Oncol. 2014. PMID: 25300718 Free article.
ESTRO-ACROP guideline "target delineation of glioblastomas".
Niyazi M, Brada M, Chalmers AJ, Combs SE, Erridge SC, Fiorentino A, Grosu AL, Lagerwaard FJ, Minniti G, Mirimanoff RO, Ricardi U, Short SC, Weber DC, Belka C. Niyazi M, et al. Radiother Oncol. 2016 Jan;118(1):35-42. doi: 10.1016/j.radonc.2015.12.003. Epub 2016 Jan 6. Radiother Oncol. 2016. PMID: 26777122
ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma.
Niyazi M, Andratschke N, Bendszus M, Chalmers AJ, Erridge SC, Galldiks N, Lagerwaard FJ, Navarria P, Munck Af Rosenschöld P, Ricardi U, van den Bent MJ, Weller M, Belka C, Minniti G. Niyazi M, et al. Radiother Oncol. 2023 Jul;184:109663. doi: 10.1016/j.radonc.2023.109663. Epub 2023 Apr 13. Radiother Oncol. 2023. PMID: 37059335 Free article.
Radiotherapy for pituitary adenomas: long-term efficacy and toxicity.
Erridge SC, Conkey DS, Stockton D, Strachan MW, Statham PF, Whittle IR, Grant R, Kerr GR, Gregor A. Erridge SC, et al. Radiother Oncol. 2009 Dec;93(3):597-601. doi: 10.1016/j.radonc.2009.09.011. Epub 2009 Nov 10. Radiother Oncol. 2009. PMID: 19900729
Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial.
Hanna C, Kurian KM, Williams K, Watts C, Jackson A, Carruthers R, Strathdee K, Cruickshank G, Dunn L, Erridge S, Godfrey L, Jefferies S, McBain C, Sleigh R, McCormick A, Pittman M, Halford S, Chalmers AJ. Hanna C, et al. Among authors: erridge s. Neuro Oncol. 2020 Dec 18;22(12):1840-1850. doi: 10.1093/neuonc/noaa104. Neuro Oncol. 2020. PMID: 32347934 Free PMC article. Clinical Trial.
142 results